ProShares Ultra Health Care (RXL)
Fund Description
The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index.
The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the healthcare sector of the U.S. equity market. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.
Fund Snapshot Updated 06.17.2013
| Previous Close |
$62.48 |
Expense Ratio |
0.95% |
| YTD Return |
50.0% |
Avg. 30-Day Volume |
11,025 |
| 1-Year Return |
75.2% |
Market Cap |
Loading... |
| Bid |
$62.30 |
Shares Outstanding |
1,125,000 |
| Ask |
$62.62 |
Dividends |
$0.21 |
| Top 10 Holdings |
| Johnson & Johnson (JNJ) |
11.99% |
| Pfizer Inc (PFE) |
10.50% |
| Merck & Co Inc New (MRK) |
7.24% |
| Gilead Sciences Inc (GILD) |
3.89% |
| Bristol Myers Squibb Co (BMY) |
3.81% |
| Amgen Inc (AMGN) |
3.71% |
| Abbvie Inc (ABBV) |
3.40% |
| Unitedhealth Group Inc (UNH) |
3.30% |
| Abbott Labs (ABT) |
2.90% |
| Medtronic Inc (MDT) |
2.71% |
| % of Total Holdings |
53.50% |
Sector Breakdown
Geographic Breakdown
